Boothbay Fund Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $418K | Sell |
11,494
-54,161
| -82% | -$1.97M | 0.01% | 800 |
|
|
2025
Q1 | $2.38M | Buy |
65,655
+11,200
| +21% | +$406K | 0.06% | 300 |
|
|
2024
Q4 | $2.29M | Sell |
54,455
-11
| -0% | -$463 | 0.06% | 343 |
|
|
2024
Q3 | $3.03M | Buy |
+54,466
| New | +$3.03M | 0.07% | 321 |
|
|
2023
Q4 | – | Sell |
-37,591
| Closed | -$1.34M | – | 1733 |
|
|
2023
Q3 | $1.34M | Buy |
37,591
+12,797
| +52% | +$456K | 0.03% | 522 |
|
|
2023
Q2 | $1.14M | Buy |
+24,794
| New | +$1.14M | 0.03% | 636 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 1876 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 1521 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 1073 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 966 |
|
|
2020
Q1 | – | Sell |
-8,289
| Closed | -$354K | – | 926 |
|
|
2019
Q4 | $354K | Buy |
+8,289
| New | +$354K | 0.03% | 487 |
|